Glutaminasa
Los inhibidores de la glutaminasa son compuestos que inhiben la glutaminasa, una enzima que cataliza la conversión de glutamina en glutamato, un paso crítico en el metabolismo celular, especialmente en las células cancerosas. La glutaminasa desempeña un papel clave en la provisión de energía y precursores biosintéticos para las células en rápida proliferación. Los inhibidores de la glutaminasa son importantes para explorar las dependencias metabólicas en las células cancerosas y desarrollar posibles estrategias terapéuticas. En CymitQuimica, proporcionamos inhibidores de la glutaminasa para apoyar su investigación en metabolismo del cáncer, bioenergética celular y descubrimiento terapéutico.
Se han encontrado 40 productos de "Glutaminasa"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
BJJF078
CAS:<p>BJJF078, an aminopiperidine, inhibits human/mouse TG2 (IC50: 41/54 nM) and TG1 (IC50: 0.16 μM), may be used in MS studies.</p>Fórmula:C27H29N3O6SPureza:98.19%Forma y color:SoildPeso molecular:523.6LDN-27219
CAS:<p>LDN-27219 is a potent hTGase inhibitor with IC50 of 0.6 uM.</p>Fórmula:C20H16N4O2S2Pureza:99.01% - 99.38%Forma y color:SolidPeso molecular:408.5Glutaminase C-IN-2
<p>Glutaminase C-IN-2 (compound 11), an allosteric inhibitor of glutaminase C (GAC), exhibits potent inhibitory activity with an IC50 of 10.64 nM.</p>Fórmula:C24H23N7O2SPureza:98%Forma y color:SolidPeso molecular:473.55L-Methionine-DL-sulfoximine
CAS:<p>MSO blocks glutamine synthetase, impacts astroglia, and is used in convulsant research.</p>Fórmula:C5H12N2O3SPureza:99.56% - ≥98%Forma y color:White Crystalline PowderPeso molecular:180.23PROTAC TG2 degrader-1
<p>PROTAC TG2 Degrader-1 (Compound 11) is a VHL-based PROTAC that targets tissue transglutaminase (TG2) and exhibits a binding affinity with a K D of 68.9 μM.</p>Fórmula:C55H73N9O10SPureza:98%Forma y color:SolidPeso molecular:1052.29PROTAC TG2 degrader-2
<p>PROTAC TG2 degrader-2 (compound 7) is a selective competitive degrader of Transglutaminase 2 (TG2), exhibiting a dissociation constant (Kd) greater than 100 μM.</p>Fórmula:C47H57N9O6SPureza:98%Forma y color:SolidPeso molecular:876.08LM11
<p>LM11 is a transglutaminase 2 (TG2) inhibitor that exhibits activity against glioblastoma cells by maintaining TG2 in a cytotoxic conformational state.</p>Fórmula:C26H18Cl2N4O5Peso molecular:536.06543Trivalent hydroxyarsinothricn
<p>Trivalent hydroxyarsinothricn (R-AST-OH) is a covalent and irreversible inhibitor of kidney-type glutaminase (KGA). It binds to the glutamine binding site and forms a covalent bond with the cysteine residue at the active site. This compound selectively kills triple-negative breast cancer (TNBC) cells without being cytotoxic to control cell lines. KGA is an enzyme that regulates glutamine metabolism and is associated with tumor malignancy.</p>Fórmula:C4H10AsNO4Peso molecular:210.982586-Diazo-5-oxo-L-nor-Leucine
CAS:<p>6-Diazo-5-oxo-L-nor-Leucine (L-6-Diazo-5-oxonorleucine) is an antagonist of glutaminases (Ki : 6 μM).</p>Fórmula:C6H9N3O3Pureza:98.04% - 98.93%Forma y color:SolidPeso molecular:171.15GLS1 Inhibitor-7
<p>GLS1 Inhibitor-7 (compound 4d) serves as a GLS1 antagonist with an IC50 value of 46.7 μM, demonstrating potential applications in anticancer, antiaging, and</p>Fórmula:C20H17F3N4O3S2Pureza:98%Forma y color:SolidPeso molecular:482.5Glutaminase-IN-1
CAS:<p>Glutaminase-IN-1 (CB839 derivative), a glutaminase (KGA) inhibitor, has antitumor activity in an aggressive H22 hepatocellular carcinoma xenograft model.</p>Fórmula:C26H24F3N7O3SePureza:98.65% - 98.65%Forma y color:SolidPeso molecular:618.47Glutaminase-IN-3
CAS:<p>Glutaminase-IN-3 is a potent Glutaminase 1 inhibitor with potential antitumor activity and inhibits GLS1 for cancer research.</p>Fórmula:C19H19F3N6O2SPureza:98.51%Forma y color:SolidPeso molecular:452.45Glutaminase C-IN-1
CAS:<p>Glutaminase C-IN-1 (Compound 968) is a Glutaminase C allosteric inhibitor.</p>Fórmula:C27H27BrN2OPureza:99.68% - >99.99%Forma y color:SolidPeso molecular:475.42GK921
CAS:<p>GK921 is a transglutaminase 2 (TGase) inhibitor.</p>Fórmula:C21H20N4OPureza:97.44% - 99.49%Forma y color:SolidPeso molecular:344.41BPTES
CAS:<p>BPTES(IC50 of 0.16 μM) is an effective and specific GlutamiN/Ase GLS1 (KGA) inhibitor.</p>Fórmula:C24H24N6O2S3Pureza:95.83% - 99.64%Forma y color:SolidPeso molecular:524.68Telaglenastat
CAS:<p>Telaglenastat (CB 839) (IC50 of 24 nM), an effective, specific, and oral inhibitor, which is bioavailable glutaminase, for recombinant human GAC.</p>Fórmula:C26H24F3N7O3SPureza:97.57% - 99.89%Forma y color:SolidPeso molecular:571.57L-Albizziin
CAS:<p>L-Albizziin (L-beta-Ureidoalanine) is a glutamase inhibitor and is a glutaminyl-tRNA synthetase inhibitor.</p>Fórmula:C4H9N3O3Pureza:99.98%Forma y color:White PowderPeso molecular:147.13Zampilimab
CAS:<p>Zampilimab (UCB-7858) is a humanised monoclonal antibody targeting TGM2, inhibits the cross-linking transamidase activity of TG2, renal fibrosis.</p>Pureza:95%Forma y color:LiquidIrbesartan-d4
CAS:<p>Irbesartan-d4 (Irbesartan D4), a deuterated compound of Irbesartan, is an angiotensin receptor blocker and is used in the study of cardiovascular disease.</p>Fórmula:C25H28N6OPureza:>99.99%Forma y color:SolidPeso molecular:432.55VA4 TG2 inhibitor
CAS:<p>VA4 is a novel irreversible TG2 transamidase site-specific inhibitor.</p>Fórmula:C33H41N5O6SForma y color:SolidPeso molecular:635.77
